Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Bassetti

Showing results (101-110 of 113) with videos related to

Pageof 12
Sort By:
Clinical Chemistry|October 6, 2000
Sensitivity and specificity of immunological methods for the detection of anti-topoisomerase I (Scl70) autoantibodies: results of a multicenter study. The Italian Society of Laboratory Medicine Study Group on the Diagnosis of Autoimmune diseasesN Bizzaro, E Tonutti, D Villalta, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 6, 2000
Possible malignant transformation of benign lymphoepithelial parotid lesions in human immunodeficiency virus-infected patients: report of three casesV Del Bono, F Pretolesi, E Pontali, et al.
Journal of Immunological Methods|November 27, 1998
Variability between methods to determine ANA, anti-dsDNA and anti-ENA autoantibodies: a collaborative study with the biomedical industryN Bizzaro, R Tozzoli, E Tonutti, et al.
International Journal of Antimicrobial Agents|November 25, 2000
Tolerance of highly active antiretroviral therapy in HIV patients: a 3-year follow upA Beltrame, V Del Bono, M Marturano, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 27, 2003
Pharmacokinetics and pharmacodynamics of nelfinavir administered twice or thrice daily to human immunodeficiency virus type 1-infected childrenG Gatti, G Castelli-Gattinara, M Cruciani, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 18, 1997
Expression of HLA class I-specific inhibitory natural killer cell receptors in HIV-specific cytolytic T lymphocytes: impairment of specific cytolytic functionsA De Maria, A Ferraris, M Guastella, et al.
Clinical Rheumatology|December 6, 2005
Accuracy of semiquantitative immunoenzymatic methods in quantitation of anti-topoisomerase I (Scl-70) antibodiesD Villalta, N Bizzaro, S Platzgummer, et al.
The Journal of Infectious Diseases|May 1, 1995
Pentoxifylline as a supportive agent in the treatment of cerebral malaria in childrenG Di Perri, I G Di Perri, G B Monteiro, et al.
Recenti Progressi in Medicina|December 23, 1999
[Detection of anti-ENA autoantibodies in patients with systemic connective tissue diseases. Analytical variability and diagnostic sensitivity of 4 methods]D Villalta, N Bizzaro, E Tonutti, et al.
AIDS (London, England)|August 16, 2001
Puberty in perinatal HIV-1 infection: a multicentre longitudinal study of 212 childrenM de Martino, P A Tovo, L Galli, et al.
Pageof 12

Showing results (101-110 of 113) with videos related to

Sort By:
Pageof 12
Clinical Chemistry|October 6, 2000
Sensitivity and specificity of immunological methods for the detection of anti-topoisomerase I (Scl70) autoantibodies: results of a multicenter study. The Italian Society of Laboratory Medicine Study Group on the Diagnosis of Autoimmune diseasesN Bizzaro, E Tonutti, D Villalta, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 6, 2000
Possible malignant transformation of benign lymphoepithelial parotid lesions in human immunodeficiency virus-infected patients: report of three casesV Del Bono, F Pretolesi, E Pontali, et al.
Journal of Immunological Methods|November 27, 1998
Variability between methods to determine ANA, anti-dsDNA and anti-ENA autoantibodies: a collaborative study with the biomedical industryN Bizzaro, R Tozzoli, E Tonutti, et al.
International Journal of Antimicrobial Agents|November 25, 2000
Tolerance of highly active antiretroviral therapy in HIV patients: a 3-year follow upA Beltrame, V Del Bono, M Marturano, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 27, 2003
Pharmacokinetics and pharmacodynamics of nelfinavir administered twice or thrice daily to human immunodeficiency virus type 1-infected childrenG Gatti, G Castelli-Gattinara, M Cruciani, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 18, 1997
Expression of HLA class I-specific inhibitory natural killer cell receptors in HIV-specific cytolytic T lymphocytes: impairment of specific cytolytic functionsA De Maria, A Ferraris, M Guastella, et al.
Clinical Rheumatology|December 6, 2005
Accuracy of semiquantitative immunoenzymatic methods in quantitation of anti-topoisomerase I (Scl-70) antibodiesD Villalta, N Bizzaro, S Platzgummer, et al.
The Journal of Infectious Diseases|May 1, 1995
Pentoxifylline as a supportive agent in the treatment of cerebral malaria in childrenG Di Perri, I G Di Perri, G B Monteiro, et al.
Recenti Progressi in Medicina|December 23, 1999
[Detection of anti-ENA autoantibodies in patients with systemic connective tissue diseases. Analytical variability and diagnostic sensitivity of 4 methods]D Villalta, N Bizzaro, E Tonutti, et al.
AIDS (London, England)|August 16, 2001
Puberty in perinatal HIV-1 infection: a multicentre longitudinal study of 212 childrenM de Martino, P A Tovo, L Galli, et al.
Pageof 12